In addition, studies show that phosphorylated WWOX is able to physically bind to the PPxY motif of WBP2 and inhibit the ER transactivation pathway, further attenuating the process of breast cancer [21, 80] (Fig. 2d). Here, WWOX is linked to breast carcinoma.